Literature DB >> 20829189

MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy.

Thomas Neumann1, Malte Kuniss, Guido Conradi, Sebastien Janin, Alexander Berkowitsch, Maciej Wojcik, Johannes Rixe, Damir Erkapic, Sergey Zaltsberg, Andreas Rolf, Georg Bachmann, Thorsten Dill, Christian W Hamm, Heinz-Friedrich Pitschner.   

Abstract

AIMS: Cerebral embolism is a possible serious complication during catheter ablation of atrial fibrillation (AF). The purpose of this prospective pilot study was to analyse the incidence and possible impact of cryo ablation on cerebral lesions and possible differences to radiofrequency (RF) ablation during pulmonary vein isolation (PVI). METHODS AND
RESULTS: Pulmonary vein isolation was performed in 89 patients, either with the cryoballoon technique (n = 45) or with RF ablation (n = 44). Phenprocoumon was stopped 3 days before intervention and replaced by subcutaneous low-molecular-weight heparin. During the catheter procedure, an infusion of unfractionated heparin was maintained to achieve an activated clotting time (ACT) of > 300 s. Cerebral magnetic resonance imaging scans were performed 1 day before and after PVI, and at 3-month follow-up. Chronic lesions were observed in 11 patients (12.3%) before PVI without statistically significant difference between the two groups. None of the patients had neurological symptoms during or following the procedure. Seven patients (7.9%) developed acute lesions 1 day after PVI, without statistically significant difference between the group treated by cryoenergy (8.9%) and RF ablation (6.8%). Patients with acute lesions were significantly older compared with those without acute cerebral lesions. No additional cerebral lesions during follow-up were observed.
CONCLUSION: A considerable portion of patients with AF but without any neurological symptoms had chronic cerebral lesions before PVI. Additional acute lesions could be added after the procedure. Both ablation techniques showed additional cerebral acute lesions with no neurological symptoms after PVI.

Entities:  

Mesh:

Year:  2010        PMID: 20829189     DOI: 10.1093/europace/euq303

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  28 in total

1.  Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation.

Authors:  Kadri Murat Gurses; Duygu Kocyigit; Muhammed Ulvi Yalcin; Banu Evranos; Hikmet Yorgun; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto; Necla Ozer; Kudret Aytemir
Journal:  J Interv Card Electrophysiol       Date:  2015-02-28       Impact factor: 1.900

2.  Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.

Authors:  Patrick Müller; Johannes Maier; Johannes-Wolfgang Dietrich; Sebastian Barth; Daniel P Griese; Fabian Schiedat; Attila Szöllösi; Philipp Halbfass; Karin Nentwich; Markus Roos; Joachim Krug; Anja Schade; Rainer Schmitt; Andreas Mügge; Thomas Deneke
Journal:  J Interv Card Electrophysiol       Date:  2015-06-06       Impact factor: 1.900

Review 3.  Collateral Damage During Ablation of Atrial Fibrillation - Lessons Learnt in the Past Decade.

Authors:  David Spragg
Journal:  J Atr Fibrillation       Date:  2012-02-02

Review 4.  Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta-analysis.

Authors:  Chao-Feng Chen; Xiao-Fei Gao; Xu Duan; Bin Chen; Xiao-Hua Liu; Yi-Zhou Xu
Journal:  J Interv Card Electrophysiol       Date:  2017-01-07       Impact factor: 1.900

Review 5.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

6.  Comparing Safety and Efficacy of Irrigated Radiofrequency Catheter Ablation Versus Combined Cryoballoon and Catheter Ablation for Persistent Atrial Fibrillation.

Authors:  Ioanna Kosmidou; Kyari Sumayin; Thomas Deering; Andrew Wickliffe; Sricharan Kanitpudi; Stephen Prater; Dan Dan
Journal:  J Atr Fibrillation       Date:  2013-10-31

Review 7.  Atrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.

Authors:  Christopher V DeSimone; Elisa Madhavan; Sébastien Ebrille; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 8.  Cerebral Embolization During AF Ablation -Pathophysiology, Prevention and Management.

Authors:  Nasir Shariff; Nagesh Antha; Manish Roy; Hari Joshi; Vadim Levin
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 9.  Atrial Fibrillation and Stroke: Increasing Stroke Risk with Intervention.

Authors:  Christopher V DeSimone; Malini Madhavan; Elisa Ebrille; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Card Electrophysiol Clin       Date:  2014-03

Review 10.  Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.

Authors:  Marcin Kowalski; Valay Parikh
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.